Foghorn Therapeutics (FHTX) Shares Outstanding (Diluted) (2020 - 2026)
Powered by 
Analysis
Foghorn Therapeutics (FHTX) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Foghorn Therapeutics | 346.08 Mn | 278.00 Mn | - | 70.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 70.63 Mn |
| Mar 31, 2026 | 69.54 Mn |
| Dec 31, 2025 | 62.98 Mn |
| Sep 30, 2025 | 63.03 Mn |
| Jun 30, 2025 | 62.98 Mn |
| Mar 31, 2025 | 62.85 Mn |
| Dec 31, 2024 | 54.90 Mn |
| Sep 30, 2024 | 62.60 Mn |
| Jun 30, 2024 | 51.58 Mn |
| Mar 31, 2024 | 42.43 Mn |
| Dec 31, 2023 | 41.97 Mn |
| Sep 30, 2023 | 42.03 Mn |
| Jun 30, 2023 | 41.83 Mn |
| Mar 31, 2023 | 41.81 Mn |
| Dec 31, 2022 | 41.59 Mn |
| Sep 30, 2022 | 41.67 Mn |
| Jun 30, 2022 | 41.52 Mn |
| Mar 31, 2022 | 41.37 Mn |
| Dec 31, 2021 | 37.17 Mn |
| Sep 30, 2021 | 36.97 Mn |